Literature DB >> 34260050

The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.

Patrick O Sakyi1,2, Richard K Amewu1, Robert N O A Devine2, Emahi Ismaila2, Whelton A Miller3,4,5, Samuel K Kwofie6,7.   

Abstract

Despite advancements in the areas of omics and chemoinformatics, potent novel biotherapeutic molecules with new modes of actions are needed for leishmaniasis. The socioeconomic burden of leishmaniasis remains alarming in endemic regions. Currently, reports from existing endemic areas such as Nepal, Iran, Brazil, India, Sudan and Afghanistan, as well as newly affected countries such as Peru, Bolivia and Somalia indicate concerns of chemoresistance to the classical antimonial treatment. As a result, effective antileishmanial agents which are safe and affordable are urgently needed. Natural products from both flora and fauna have contributed immensely to chemotherapeutics and serve as vital sources of new chemical agents. This review focuses on a systematic cross-sectional view of all characterized anti-leishmanial compounds from natural sources over the last decade. Furthermore, IC50/EC50, cytotoxicity and suggested mechanisms of action of some of these natural products are provided. The natural product classification includes alkaloids, terpenes, terpenoids, and phenolics. The plethora of reported mechanisms involve calcium channel inhibition, immunomodulation and apoptosis. Making available enriched data pertaining to bioactivity and mechanisms of natural products complement current efforts geared towards unraveling potent leishmanicides of therapeutic relevance.
© 2021. The Author(s).

Entities:  

Keywords:  Chemoinformatics; Chemotherapeutics; Cytotoxicity; Leishmaniasis; Natural products; Phenotypic screening

Year:  2021        PMID: 34260050     DOI: 10.1007/s13659-021-00311-2

Source DB:  PubMed          Journal:  Nat Prod Bioprospect        ISSN: 2192-2209


  82 in total

Review 1.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

Review 3.  Vaccines for visceral leishmaniasis: A review.

Authors:  Keerti Jain; N K Jain
Journal:  J Immunol Methods       Date:  2015-04-07       Impact factor: 2.303

Review 4.  Recent advances in leishmaniasis treatment.

Authors:  Tatiana S Tiuman; Adriana O Santos; Tânia Ueda-Nakamura; Benedito P Dias Filho; Celso V Nakamura
Journal:  Int J Infect Dis       Date:  2011-05-24       Impact factor: 3.623

Review 5.  Social and Economic Burden of Human Leishmaniasis.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Am J Trop Med Hyg       Date:  2016-01-19       Impact factor: 2.345

Review 6.  Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

Authors:  Piero L Olliaro; Philippe J Guerin; Sibylle Gerstl; Astrid Aga Haaskjold; John-Arne Rottingen; Shyam Sundar
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

Review 7.  An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.

Authors:  Saeed Emami; Pegah Tavangar; Masoud Keighobadi
Journal:  Eur J Med Chem       Date:  2017-04-21       Impact factor: 6.514

8.  Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.

Authors:  Goutam Mandal; Srotoswati Mandal; Mansi Sharma; Karen Santos Charret; Barbara Papadopoulou; Hiranmoy Bhattacharjee; Rita Mukhopadhyay
Journal:  PLoS Negl Trop Dis       Date:  2015-02-25

Review 9.  Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.

Authors:  Ana C O Souza; Andre C Amaral
Journal:  Front Microbiol       Date:  2017-03-07       Impact factor: 5.640

10.  Understanding Resistance vs. Susceptibility in Visceral Leishmaniasis Using Mouse Models of Leishmania infantum Infection.

Authors:  Begoña Pérez-Cabezas; Pedro Cecílio; Tiago Bordeira Gaspar; Fátima Gärtner; Rita Vasconcellos; Anabela Cordeiro-da-Silva
Journal:  Front Cell Infect Microbiol       Date:  2019-03-01       Impact factor: 5.293

View more
  3 in total

Review 1.  Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets.

Authors:  Richard Kwamla Amewu; Patrick Opare Sakyi; Dorcas Osei-Safo; Ivan Addae-Mensah
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

2.  Antileishmanial Effects of Acetylene Acetogenins from Seeds of Porcelia macrocarpa (Warm.) R.E. Fries (Annonaceae) and Semisynthetic Derivatives.

Authors:  Ivanildo A Brito; Fernanda Thevenard; Thais A Costa-Silva; Samuel S Oliveira; Rodrigo L O R Cunha; Emerson A de Oliveira; Patricia Sartorelli; Rafael C Guadagnin; Maiara M Romanelli; Andre G Tempone; João Henrique G Lago
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

3.  Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase.

Authors:  Patrick O Sakyi; Emmanuel Broni; Richard K Amewu; Whelton A Miller; Michael D Wilson; Samuel Kojo Kwofie
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.